Pump up your possibilities — and win a new iPhone 16!§
We're celebrating the launch of the new Tandem mobile app* which now lets you bolus from your smartphone*,^ with something big.
From July 1st, if you order the Tandem t:slim X2™ insulin pump, you’ll go in the draw to win a brand-new iPhone 16.
T&C's apply.§
.jpg?width=2000&height=2000&name=iPhone%20giveaway_creative_1x1-min%20(1).jpg "iPhone giveaway_creative_1x1-min (1)")
The t:slim X2™ insulin pump with Control-IQ™ technology can be used as a stand alone pump, or can be integrated with the Dexcom G7 or G6 continuous glucose monitoring (CGM)† system to activate the predictive insulin delivery technology.
The Control‑IQ advanced hybrid closed-loop technology makes it easier by using Dexcom CGM values to predict glucose levels 30 minutes ahead and automatically adjusts basal insulin every 5 minutes, to help increase time in range.1
NEW Tandem t:slim mobile app*
Give yourself the freedom to more easily manage your glucose level with the Tandem t:slim mobile app*
Even when you forget your phone, the pump will continue to automatically adjust insulin delivery¶ without interruption.
Freedom to bolus
Bolus from your compatible smartphone*,^ without touching your t:slim X2 insulin pump.
Freedom to be discreet
View pump data on your smartphone as a secondary display for your t:slim X2 insulin pump.
Freedom to be in the know
Automatically upload your pump data to the new Tandem Source platform.#
Check your device’s compatibility here before you download the app.
Why choose Tandem?
Quick and easy
- Quick and simple set up.
- 97% said it’s easy to use.2
- Slim, sleek, user-friendly colour touchscreen and holds up to 300 units of insulin for added convenience and less frequent cartridge changes.
- The only pump with flexible bolus options, giving you the choice to bolus from your smartphone*, ^ or pump.
- AutoBolus feature helps automatically deliver boluses|| for when you forget to bolus or miscount carbs.
Customisable to your lifestyle
- Freedom to disconnect - For planned or spontaneous activities such as showering, swimming, sports etc.
- Flexible wear locations and a variety of infusion sets to meet your needs.
- Adaptive options to support sleep and exercise activities for tighter control throughout the day and night.
Proven Health Outcomes3-5
- The only automated insulin delivery system featuring Sleep Activity designed to support better overnight glucose control. Giving you the freedom to focus on what truly matters during the day.
- Immediate increase of 11.5% time in range on Day 1.4
- Reduction in glucose management distress such as having a bad night’s sleep and missing work/school.3
Have you heard of our loan programs?
At AMSL Diabetes, we strive to remove barriers to access to advanced glucose management technology. We're excited to introduce our tailored loan streams for t:slim X2 insulin pump, aimed at supporting early initiation and flexible management for people living with type 1 diabetes.
Give it a Try
The Give it a Try initiative allows a two-month trial with the t:slim X2 insulin pump, subject to application approval and certain conditions. It provides an opportunity for individuals to experience the pump's benefits first hand.
Accelerate & Pump
Don't wait for your health insurance to mature, start pumping with a t:slim X2 insulin pump through AMSL Diabetes Accelerate & Pump program.
ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on amsldiabetes.com.au/resources before purchasing. Consult your healthcare professional to see if this product is right for you.
The Tandem t:slim Mobile App is an accessory intended for use as a connected software device that is able to reliably and securely communicate with compatible insulin pumps. Tandem Source is a web application intended to support glucose management through the display and analysis of information uploaded from Tandem insulin pumps. The t:slim X2 insulin pump is a portable insulin infusion pump, including sterile cartridge, that delivers insulin subcutaneously through a disposable infusion set. Dexcom CGM is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated.
‡ If your glucose alerts and readings from Dexcom G7 do not match symptoms or expectations use a blood glucose meter to make diabetes treatment decisions. § Competition ends 30 Sept 2025. Further T&Cs apply, visit. https://amsldiabetes.com.au/trading-terms *Bolus delivery from the Tandem t:slim mobile app requires a compatible smartphone model and operating system, software version 7.8.1 onwards on the t:slim X2 insulin pump and additional training. ^Smart device sold separately. To view a list of compatible devices, visit https://amsldiabetes.com.au/mobile-compatibility. †Dexcom G7 sold separately. Subsidised Dexcom CGM is available through the CGM Subsidy Initiative via the NDSS for eligible individuals, for more information visit ndss.com.au/cgm. ||Up to one per hour if necessary. If glucose values are predicted to be above 10.0 mmol/L, Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 6.1 mmol/L and delivers 60% of that value. ¶As measured by CGM. CGM sold separately. # Uploads to the Tandem Source platform do not take place in real- time and should not be relied upon by healthcare providers, pump users, or caregivers for remote patient monitoring.
1. Beck RW, Kanapka LG, Breton MD, Brown SA, Wadwa RP, Buckingham BA, Kollman C, Kovatchev B. A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72. Diabetes Technol Ther. 2023 May;25(5):329-342. doi: 10.1089/dia.2022.0558. Epub 2023 Apr 12. PMID: 37067353; PMCID: PMC10171957.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom G6, Dexcom G7, Dexcom ONE+, Dexcom Share, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. ©2025 Dexcom, Inc. All rights reserved.
© 2025 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Control-IQ, and t:slim X2 are registered trademarks or trademarks of Tandem Diabetes Care, Inc.
Australasian Medical & Scientific Ltd is a Dexcom company.